| Date | Time | Source | Headline | Symbol | Company |
| 01/20/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Trading Update | LSE:MXCT | Maxcyte Inc |
| 01/11/2021 | 9:51AM | Alliance News |  UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020 | LSE:MXCT | Maxcyte Inc |
| 01/11/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Myeloid Therapeutics Clinical & Commercial License | LSE:MXCT | Maxcyte Inc |
| 12/23/2020 | 5:36AM | Alliance News | Maxcyte Core Life Sciences Business Results To Beat Expectations | LSE:MXCT | Maxcyte Inc |
| 12/23/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Trading Update | LSE:MXCT | Maxcyte Inc |
| 11/09/2020 | 8:00AM | UK Regulatory | MaxCyte, Inc. CARMA Cell Therapies at SITC 2020 | LSE:MXCT | Maxcyte Inc |
| 11/09/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Presentations at Upcoming Virtual IR Conferences | LSE:MXCT | Maxcyte Inc |
| 11/02/2020 | 10:52AM | UK Regulatory | MaxCyte, Inc. Result of AGM | LSE:MXCT | Maxcyte Inc |
| 10/22/2020 | 1:22PM | UK Regulatory | MaxCyte, Inc. Disclosure of Remuneration for Non-Audit Services | LSE:MXCT | Maxcyte Inc |
| 10/14/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Notification of AGM and Audit Declaration | LSE:MXCT | Maxcyte Inc |
| 10/13/2020 | 9:06AM | Alliance News | UK EXECUTIVE CHANGE SUMMARY: Danakali Hires Potash Mining Vet As COO | LSE:MXCT | Maxcyte Inc |
| 10/13/2020 | 2:00AM | RNS Non-Regulatory | MaxCyte, Inc. MaxCyte announces leadership appointments | LSE:MXCT | Maxcyte Inc |
| 10/01/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Director/PDMR Shareholding | LSE:MXCT | Maxcyte Inc |
| 09/21/2020 | 11:24AM | Alliance News | IN BRIEF: MaxCyte Interim Revenue Jumps And Loss Narrows | LSE:MXCT | Maxcyte Inc |
| 09/21/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Results for the Six Months ended 30 June 2020 | LSE:MXCT | Maxcyte Inc |
| 09/10/2020 | 8:42AM | UK Regulatory | MaxCyte, Inc. Grant of options | LSE:MXCT | Maxcyte Inc |
| 09/10/2020 | 2:00AM | RNS Non-Regulatory | MaxCyte, Inc. HC Wainright & Co Virtual Conference Presentation | LSE:MXCT | Maxcyte Inc |
| 09/09/2020 | 9:28AM | Alliance News | MaxCyte Hires Murphy As Finance Chief; Holtz Becomes Accounting Boss | LSE:MXCT | Maxcyte Inc |
| 09/09/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Appointment of Amanda L. Murphy as CFO | LSE:MXCT | Maxcyte Inc |
| 09/02/2020 | 9:57AM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 09/02/2020 | 2:06AM | UK Regulatory | MaxCyte, Inc. Notice of Half Year Results | LSE:MXCT | Maxcyte Inc |
| 08/18/2020 | 3:04PM | Alliance News | IN BRIEF: MaxCyte Says CARMA's Phase 1 MCY-M11 Trial Expanded | LSE:MXCT | Maxcyte Inc |
| 08/18/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Expansion of CARMA's Phase I Trial of MCY-M11 | LSE:MXCT | Maxcyte Inc |
| 08/14/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 07/16/2020 | 1:04PM | UK Regulatory | MaxCyte, Inc. Director Dealings and Issue of Equity | LSE:MXCT | Maxcyte Inc |
| 07/15/2020 | 8:31AM | Alliance News | MaxCyte Sees Higher Interim Revenue, Confident On Long-Term Prospects | LSE:MXCT | Maxcyte Inc |
| 07/15/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Trading Update | LSE:MXCT | Maxcyte Inc |
| 07/08/2020 | 10:51AM | Alliance News | IN BRIEF: MaxCyte Signs APN401 Licensing Deal With Apeiron Biologics | LSE:MXCT | Maxcyte Inc |
| 07/08/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. APEIRON Biologics Clinical and Commercial License | LSE:MXCT | Maxcyte Inc |
| 07/01/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Block Listing Return & TVR | LSE:MXCT | Maxcyte Inc |